Comparison between hyperbaric ropivacaine alone and hyperbaric ropivacaine with fentanyl for spinal anesthesia in condition of intravenous dexmedetomidine sedation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005116

Enrollment

Registered

2020-06-12

Start date

2020-07-06

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Subjects are randomly assigned to a group of 0.5% Hyperbaric ropivacaine 15 mg (3 mL) or 0.5% Hyperbaric ropivacaine 15 mg + fentanyl 20 ug (3.4 mL) using a computer programmed randomization. I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -American society of anesthesiologists(ASA) physical status I,II,III -Patients who are 20 years of age or older and 70 years or younger who agree to participate in the study -Patients undergoing surgery under spinal anesthesia

Exclusion criteria

Exclusion criteria: -Patient refusal -Local infection of puncture site -Coagulopathy -Allergy to drugs for study -History of spinal operation(lumbar region) -Severe spinal deformity, severe spinal stenosis -Psycosis, Uncooperative patients -BMI>30 -Morbid cardiovascular impairment or Ejection fraction<45%

Design outcomes

Primary

Measure	Time frame
Time that takes for 2 dermatome regression	—

Secondary

Measure	Time frame
Side effects after anesthesia(hypotension, bradycardia, nausea, vomiting, pruritis);The first time painkillers were requested and the cumulative dose of painkillers within 24 hours of surgery	—

Countries

Korea, Republic of

Contacts

Public ContactTaehyung Kim

Dong-A University Hospital

scc13579@naver.com+82-51-240-5390

Outcome results